Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
Objective: Doxorubicin (Dox) is used clinically against various neoplasias, but suffers from serious side effects, and for the past three decades, this shortcoming has spurred research towards finding better drug delivery systems (DDSs) for this frontline drug. Methods: A non-targeted nucleotropic D...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Blackwell Publishing Ltd
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/47010 |